P. Buszman

发表

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

S. Cook, M. Meuwissen, C. von Birgelen, 2018, British Medical Journal.

Non-Invasive Coronary Imaging

S. Achenbach, G. Raff, M. Oudkerk, 2008 .

[Guidelines on the management of stable angina pectoris: executive summary].

J. Camm, K. Dickstein, S. Priori, 2006, Giornale italiano di cardiologia.

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial.

P. Serruys, J. Tijssen, P. Jüni, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction

P. Serruys, J. Iqbal, S. Windecker, 2014, Heart.

Long-term outcomes of transcatheter self-expanding aortic valve implantations in inoperable and high surgical-risk patients with severe aortic stenosis: a single-center single-valve registry.

P. Buszman, A. Bochenek, J. Zejda, 2021, Kardiologia polska.

[Massive pulmonary embolism mimicking ST-elevation acute coronary syndrome successfully treated with hybrid therapy in a trauma patient receiving nadroparin: diagnostic and therapeutic dilemmas].

P. Buszman, W. Piwowarska, P. Latacz, 2007, Kardiologia polska.

Influence of heart rate on FFR measurements: An experimental and clinical validation study.

P. Serruys, P. Buszman, J. Bartunek, 2020, International journal of cardiology.

Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy.

M. Tendera, P. Buszman, T. Bochenek, 2007, The American journal of cardiology.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, P. Jüni, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomized Trial of Percutaneous Coronary Intervention for Subacute Infarct-Related Coronary Artery Occlusion to Achieve Long-Term Patency and Improve Ventricular Function: The Total Occlusion Study of Canada (TOSCA)–2 Trial

G. Lamas, G. Knatterud, C. Buller, 2006, Circulation.

Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease.

P. Buszman, W. Wojakowski, K. Milewski, 2013, Cardiology journal.

Percutaneous versus surgical revascularization for multivessel coronary artery disease: A single center 10 year follow‐up of SOS trial patients

R. Stables, M. Tendera, Jack L. Martin, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction.

Wojciech Wojakowski, Joanna Ciosek, M. Tendera, 2009, Journal of the American College of Cardiology.

Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cells.

M. Tendera, M. Ratajczak, P. Buszman, 2010, International journal of oncology.

424 Mobilization of CXCR4+/CD34+ stem cells early in acute myocardial infarction is correlated with left ventricular ejection fraction and NT-proBNP levels after 1 year of follow-up (MRI study)

M. Tendera, M. Ratajczak, P. Buszman, 2006 .

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2019, European heart journal.

A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".

S. Cook, C. von Birgelen, Elvin Kedhi, 2017, American heart journal.

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study

P. Serruys, A. Íñiguez, D. Dudek, 2021, European heart journal.

Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.

Jack L. Martin, A. Zurakowski, P. Buszman, 2016, JACC. Cardiovascular interventions.

Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model.

J. Granada, P. Buszman, J. Prats, 2012, Thrombosis research.

Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.

G. Lamas, M. Pfisterer, C. Buller, 2009, American heart journal.

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions.

F. Eberli, P. Serruys, S. Silber, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of stenting and surgical revascularization strategy in non-ST elevation acute coronary syndromes and complex coronary artery disease (from the Milestone Registry).

M. Zembala, P. Buszman, A. Bochenek, 2014, The American journal of cardiology.

The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the PL-ACS registry.

M. Zembala, P. Buszman, Z. Kalarus, 2012, Kardiologia polska.

2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.

H. Thiele, A. Baumbach, A. Lansky, 2019, JACC. Cardiovascular interventions.

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial

H. Thiele, A. Baumbach, A. Lansky, 2018, The Lancet.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

S. Pocock, P. Serruys, G. Stone, 2016, The New England journal of medicine.

Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry.

M. Tendera, Jack L. Martin, A. Zurakowski, 2009, Journal of the American College of Cardiology.

An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer‐coated sirolimus‐eluting stents

D. Dudek, G. Mintz, J. Jąkała, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock: CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry

D. Dudek, J. Stȩpińska, P. Buszman, 2021, Journal of clinical medicine.

Bivalirudin use in acute coronary syndrome patients undergoing percutaneous coronary interventions in Poland: Clinical update from expert group of the Association on Cardiovascular Interventions of the Polish Cardiac Society

J. Wójcik, D. Dudek, M. Jaguszewski, 2019, Cardiology journal.

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

P. Serruys, A. Íñiguez, D. Dudek, 2017, European heart journal.

Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial

P. Serruys, G. Stone, D. Kandzari, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Resolute zotarolimus‐eluting stent in ST‐elevation myocardial infarction (resolute‐STEMI): A prespecified prospective register from the DAPT‐STEMI trial

S. Cook, G. De Luca, Elvin Kedhi, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention

P. Serruys, S. Silber, S. Windecker, 2014, Journal of the American College of Cardiology.

Interventional Cardiology 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents A Report From the RESOLUTE All-Comers Trial ( A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutan

P. Serruys, S. Silber, S. Windecker, 2022 .

Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).

D. Dudek, A. Więcek, K. Narkiewicz, 2016, Kardiologia polska.

Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.

D. Dudek, M. Tendera, Jack L. Martin, 2008, Journal of the American College of Cardiology.

Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland

P. Buszman, Yuchen Xia, J. Zejda, 2021, International journal of environmental research and public health.

Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

O. Alfieri, I. Palacios, P. Serruys, 2012, JACC. Cardiovascular interventions.

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

P. Serruys, P. Jüni, S. Garg, 2019, Journal of the American College of Cardiology.

Intracoronary adiponectin at reperfusion reduces infarct size in a porcine myocardial infarction model.

P. Buszman, Jack Martin, A. Bochenek, 2011, International journal of molecular medicine.

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem

M. Tendera, S. Grajek, M. Ratajczak, 2009, European heart journal.

Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine

J. Granada, A. Zurakowski, P. Buszman, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.

J. Granada, P. Buszman, A. Tellez, 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intra

P. Armstrong, C. Granger, C. Grines, 2009, American heart journal.

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2019, Clinical Research in Cardiology.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

S. Pocock, P. Serruys, G. Stone, 2019, The New England journal of medicine.

Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.

G. De Luca, Y. Song, H. Gwon, 2020, Atherosclerosis.

Renal Artery Stenting Associated With Improvement in Renal Function and Blood Pressure Control in Long-Term Follow-Up

P. Buszman, W. Wańha, W. Wojakowski, 2016, Kidney and Blood Pressure Research.

Treatment of symptomatic coronary artery disease in patients with end‐stage renal disease on hemodialysis with paclitaxel‐eluting TAXUS stent

Jack L. Martin, P. Buszman, P. Buszman, 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database.

M. Zembala, M. Tendera, P. Buszman, 2016, Polskie Archiwum Medycyny Wewnetrznej.

Utilisation of bivalirudin and vascular closure devices for same-day discharge after percutaneous coronary and peripheral interventions.

P. Buszman, Marcin Dębiński, M. Kondys, 2016, Kardiologia polska.

Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology

Udo Hoffmann, Geoffrey D. Rubin, Pawel Buszman, 2007, The International Journal of Cardiovascular Imaging.

Sinus of Valsalva aneurysm.

P. Buszman, M. Krejca, M. Sosnowski, 2009, Cardiology journal.

Clinical Characteristics, Treatments, and Outcomes of Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Results from a Multicenter National Registry

P. Buszman, P. Gąsior, Z. Kalarus, 2020, Journal of clinical medicine.

Five-year outcomes after revascularization of superficial femoral artery occlusion using Ocelot catheter

P. Buszman, P. Buszman, A. Janas, 2019, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Long‐term results of plaque excision combined with aggressive pharmacotherapy in high‐Risk patients with advanced peripheral artery disease (SAVE a LEG registry)

Jack L. Martin, P. Buszman, M. Radvany, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Microcrystalline paclitaxel-coated balloon for revascularization of femoropopliteal artery disease: Three-year outcomes of the randomized BIOPAC trial

J. Granada, A. Zurakowski, P. Buszman, 2021, Vascular medicine.

State-of-the-art of transcatheter treatment of aortic valve stenosis and the overview of the InFlow project aiming at developing the first Polish TAVI system.

A. Mezyk, P. Buszman, J. Kasperczyk, 2017, Cardiology journal.

The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).

Dick M. Goedhart, F. Eberli, P. Serruys, 2010, The American journal of cardiology.

Peri-procedural hemostasis disorders in surgical and transcatheter aortic valve implantation

P. Buszman, W. Domaradzki, K. Milewski, 2019, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial

J. J. Piek, Deepak L. Bhatt, P. Serruys, 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury

M. Tendera, P. Buszman, E. Zuba-Surma, 2012, Thrombosis and Haemostasis.

Low molecular weight heparin in surgical valve procedures: When and how much for an optimal prophylaxis?

P. Buszman, A. Bochenek, M. Cisowski, 2013, Cardiology journal.

Stent implantation for the unprotected left main coronary artery. The long-term outcome of 62 patients.

M. Tendera, P. Buszman, Marcin Dębiński, 2006, Kardiologia polska.

A Novel Peritoneum Derived Vascular Prosthesis Formed on a Latex Catheter in an SDF-1 Chemokine Enriched Environment: A Pilot Study

P. Buszman, A. Bochenek, D. Smyczek, 2015, The International journal of artificial organs.

Managed Care after Acute Myocardial Infarction (MC-AMI) Reduces Total Mortality in 12-Month Follow-Up—Results from a Poland’s National Health Fund Program of Comprehensive Post-MI Care—A Population-Wide Analysis

P. Jankowski, P. Buszman, E. Nowalany-Kozielska, 2020, Journal of clinical medicine.

Accelerated Atherosclerosis in Patients with Systemic Lupus Erythematosus and the Role of Selected Adipocytokines in This Process

P. Buszman, E. Hrycek, A. Hrycek, 2017 .

AS-79: Number of Circulating Progenitor Cells is a Predictor of Left Ventricular Ejection Fraction Improvement in Patients with Acute Myocardial Infarction Treated with Intracoronary Infusion of Bone Marrow–Derived CD34+CXCR4+ Cells

M. Tendera, M. Ratajczak, P. Buszman, 2010 .

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.

R. Virmani, R. Whitbourn, P. Serruys, 2004, Journal of the American College of Cardiology.

Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes.

P. Serruys, P. Jüni, S. Garg, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.

M. Tendera, A. Zurakowski, P. Buszman, 2009, Kardiologia polska.

Is neural network better than logistic regression in death prediction in patients after ST-segment elevation myocardial infarction?

D. Dudek, T. Zdrojewski, P. Buszman, 2021, Kardiologia polska.

Aborted myocardial infarction in patients with ST ‑segment elevation myocardial infarction treated with mechanical reperfusion

P. Buszman, Marcin Dębiński, M. Kondys, 2021 .

Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial.

J. Granada, A. Zurakowski, P. Buszman, 2015, Journal of interventional cardiology.

Local intravascular delivery of low-density-lipoprotein cholesterol corresponds with increased intimal thickening in a healthy porcine coronary model. A prelude to development of a model of atherosclerosis

R. Virmani, F. Kolodgie, P. Buszman, 2019, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Comparison of the Absorb bioresorbable vascular scaffold to the Xience durable polymer everolimus-eluting metallic stent in routine clinical practice: a propensity score-matched analysis from a multicenter registry

P. Buszman, K. Milewski, P. Buszman, 2018, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction.

P. Buszman, Z. Kalarus, M. Gąsior, 1995, European heart journal.

First generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the LEADERS all‐comers randomized trial

F. Eberli, P. Serruys, R. D. de Winter, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.

P. Serruys, J. Wykrzykowska, S. Windecker, 2016, Cardiology journal.

Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.

F. Eberli, P. Serruys, J. Wykrzykowska, 2009, JACC. Cardiovascular interventions.

Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).

O. Alfieri, I. Palacios, P. Serruys, 2014, The American journal of cardiology.

[Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris].

P. Hjemdahl, D. Ardissino, J. Morais, 2006, Kardiologia polska.

Transcatheter Versus Surgical Valve Replacement: A 24-months Propensity-matched Analysis of the SILCARD Registry

M. Zembala, P. Buszman, A. Bochenek, 2022, Anatolian journal of cardiology.

One-stage hybrid coronary revascularization for the treatment of multivessel coronary artery disease— Periprocedural and long-term results from the “HYBRID-COR” feasibility study

P. Buszman, A. Bochenek, M. Cisowski, 2022, Frontiers in Cardiovascular Medicine.

Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.

A. Zurakowski, P. Buszman, K. Milewski, 2010, Kardiologia polska.

Short and long-term results of endoscopic atraumatic coronary artery off-pump bypass grafting in patients with left anterior descending artery stenosis.

P. Buszman, A. Bochenek, M. Cisowski, 2013, Cardiology journal.

Go With the Flow When Instantaneous Wave-Free Ratio-Fractional Flow Reserve Discordance Occurs

J. Granada, A. Zurakowski, P. Buszman, 2022 .

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Cardiva Catalyst II Vascular Access Management Device in Percutaneous Diagnostic and Interventional Procedures with Same-Day Discharge (CATALYST II Trial)

Jack L. Martin, P. Buszman, P. Buszman, 2011, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

6-Month Evaluation of a Transcatheter Aortic Valve (Myval) in a Novel Ovine, Supra-Aortic Banding Model

P. Buszman, A. Tellez, S. Rousselle, 2022, JACC. Basic to translational science.

[Percutaneous revascularisation of subacute occlusion of the left subclavian artery manifesting as acute coronary syndrome in a patient after coronary artery bypass grafting].

P. Buszman, P. Latacz, P. Rostoff, 2010, Kardiologia polska.

Temporal healing patterns and coverage dynamics after new Polish transcatheter PFO occluder implantation in a swine.

R. Gil, P. Buszman, Przemysław Węglarz, 2017, Kardiologia polska.

[Successful recanalisation of RCA CTO using retrograde approach].

P. Buszman, M. Król, B. Skwarna, 2009, Kardiologia polska.

New treatment possibilities for patients with advanced coronary artery disease and critical limb ischemia – a feasibility study

A. Zurakowski, P. Buszman, P. Nowakowski, 2016, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

The role of CXCR4/SDF-1, CD117/SCF, and c-met/HGF chemokine signalling in the mobilization of progenitor cells and the parameters of the left ventricular function, remodelling, and myocardial perfusion following acute myocardial infarction

M. Tendera, M. Ratajczak, P. Buszman, 2008 .

Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease.

M. Tendera, Jack L. Martin, P. Buszman, 2009, The Journal of invasive cardiology.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Controlled Release of Encapsuled Stromal-Derived Factor 1α Improves Bone Marrow Mesenchymal Stromal Cells Migration

P. Buszman, J. Kasperczyk, K. Jelonek, 2022, Bioengineering.

Long-Term Outcomes After Percutaneous Lower Extremity Arterial Interventions With Atherectomy vs. Balloon Angioplasty　- Propensity Score-Matched Registry.

P. Buszman, W. Wojakowski, K. Milewski, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Selected adipokines and thickness of the intima-media complex in patients with systemic lupus erythematosus.

A. Zurakowski, P. Buszman, A. Franek, 2018, Kardiologia polska.

Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries

M. Jahangiri, M. Mayr, U. Mayr, 2018, Circulation.

A randomized comparison of elective high-pressure stenting with balloon angioplasty: six-month angiographic and two-year clinical follow-up. On behalf of AS (Angioplasty or Stent) trial investigators.

P. Buszman, A. Witkowski, W. Rużyłło, 2000, American heart journal.

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomi

F. Eberli, P. Serruys, S. Windecker, 2022 .

Safety and biocompatibility of a novel self-expanding nitinol carotid stent with hybrid cell design in a porcine model of neointimal hyperplasia.

J. Lapointe, P. Buszman, W. Wojakowski, 2015, Kardiologia polska.

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.

Maya B. Mathur, M. Desai, G. Schuler, 2016, Kidney international.

[Percutaneous closure of a congenital coronary artery fistula with the use of graftstent - a case report].

A. Zurakowski, P. Buszman, T. Bochenek, 2008, Kardiologia polska.

Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.

B. Gersh, P. Serruys, G. Stone, 2019, The American journal of cardiology.

Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology

G. Raff, M. Oudkerk, G. Rubin, 2007, European Radiology.

New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.

B. Gersh, P. Serruys, G. Stone, 2018, Journal of the American College of Cardiology.

Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

Frits Mastik, Pawel Buszman, Patrick W Serruys, 2008, Circulation.

Temporal, biomechanical evaluation of a novel, transcatheter polymeric aortic valve in ovine aortic banding model

P. Buszman, Mateusz Stojko, A. Bochenek, 2022, Frontiers in Cardiovascular Medicine.

Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study.

P. Serruys, J. Wykrzykowska, D. Dudek, 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[Percutaneous ablation of the segmental renal artery for the treatment of the arterio-pelvic fistula complicating percutaneous nephrolithotomy--a case report].

P. Buszman, T. Bochenek, Marcin Dębiński, 2006, Kardiologia polska.

Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial

Dick M. Goedhart, F. Eberli, P. Serruys, 2011, Circulation. Cardiovascular interventions.

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

J. Camm, K. Dickstein, S. Priori, 2006, European heart journal.

Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model.

A. Zurakowski, P. Buszman, M. Aboodi, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Local Delivery of Enoxaparin to Decrease Restenosis After Stenting: Results of Initial Multicenter Trial: Polish-American Local Lovenox NIR Assessment Study (The POLONIA Study)

M. Tendera, Jack L. Martin, P. Buszman, 2001, Circulation.

Risk assessment in patients with ST elevation myocardial infarction treated with primary percutaneous coronary angioplasty. Does reduced duration of hospital stay affect the prognosis?

P. Buszman, Marcin Dębiński, M. Kondys, 2017, Kardiologia polska.

versus ERodable Stent coating) Trial of the Randomized Multicenter LEADERS (Limus Eluted from A Durable Value of the SYNTAX Score for Risk Assessment in the All-Comers Population

F. Eberli, P. Serruys, J. Wykrzykowska, 2012 .

Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial.

F. Eberli, P. Serruys, J. Wykrzykowska, 2010, Journal of the American College of Cardiology.

The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

F. Eberli, P. Serruys, S. Windecker, 2008, The Lancet.

Angiographic and clinical outcomes of drug‐eluting versus bare metal stent deployment in the Occluded Artery Trial

C. Buller, W. Cantor, J. Hochman, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.

A. Zurakowski, P. Buszman, W. Wojakowski, 2016, Cardiology journal.

A Nuclear Magnetic Resonance Spectroscopy as a Method for Evaluation of In Vivo Poly-l-Lactide Biodegradation Kinetics From Stent-Polymer Matrices

P. Buszman, P. Gąsior, J. Kasperczyk, 2016, Journal of cardiovascular pharmacology and therapeutics.

Dose-dependent vascular response following delivery of sirolimus via fast releasing, biodegradable polymer stent matrix: an experimental study in the porcine coronary model of restenosis.

P. Buszman, W. Wojakowski, K. Milewski, 2015, Kardiologia polska.

Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.

J. Lapointe, R. Gil, P. Buszman, 2012, Kardiologia polska.

Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System.

F. Asch, G. Nickenig, P. Buszman, 2016, Journal of the American College of Cardiology.

[POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].

D. Dudek, P. Nadziakiewicz, M. Zembala, 2009, Kardiologia polska.

Drug delivery at the aortic valve tissues of healthy domestic pigs with a Paclitaxel-eluting valvuloplasty balloon.

P. Buszman, D. Cokkinos, Marcin Dębiński, 2009, Journal of interventional cardiology.

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.

Volker Klauss, Patrick W Serruys, William Wijns, 2010, The New England journal of medicine.

Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.

P. Serruys, M. Valgimigli, P. Buszman, 2008, Journal of the American College of Cardiology.

Nanospheres encapsulated everolimus delivery into arterial wall–the tissue pharmacokinetics and vascular response experimental study

P. Buszman, P. Gąsior, J. Kasperczyk, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.

P. Serruys, S. Garg, S. Windecker, 2021, Circulation. Cardiovascular quality and outcomes.

Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial.

P. Serruys, S. Garg, R. Geuns, 2020, The Canadian journal of cardiology.

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)

P. Serruys, S. Garg, S. Windecker, 2019, BMJ Open.

Original paper Taxcor for the prevention of restenosis. Polish multicentre observational study to assess the efficacy and safety of the Genius TAXCOR I stent

D. Dudek, R. Gil, P. Buszman, 2011 .

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

F. Eberli, P. Serruys, S. Windecker, 2011, The Lancet.

PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY.

P. Serruys, S. Garg, S. Windecker, 2020, European heart journal. Cardiovascular pharmacotherapy.

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutan

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Bypass surgery versus percutaneous coronary intervention for the treatment of unprotected left main disease

G. Schuler, H. Thiele, F. Mohr, 2013, Herz.

Early and late outcomes of percutaneous transluminal angioplasty of cephalad arteries.

M. Tendera, P. Buszman, L. Cierpka, 2008, Kardiologia polska.

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.

P. Serruys, S. Silber, J. Wykrzykowska, 2011, JACC. Cardiovascular interventions.

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents

P. Serruys, S. Silber, J. Iqbal, 2015, Circulation. Cardiovascular interventions.

Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2020, Circulation. Cardiovascular interventions.

The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, S. Garg, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.

F. Eberli, P. Serruys, P. Wenaweser, 2011, JACC. Cardiovascular interventions.

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

P. Serruys, R. D. de Winter, B. Hamer, 2017, The Lancet.

Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.

O. Alfieri, I. Palacios, P. Serruys, 2016, JACC. Cardiovascular interventions.

Novel paclitaxel‐eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: A prospective multicenter registry

J. Wójcik, A. Zurakowski, R. Gil, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.

D. van Klaveren, P. Serruys, J. Wykrzykowska, 2019, International journal of cardiology.

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.

F. Eberli, P. Serruys, L. Räber, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: Insights from a multicenter, propensity score‐matched registry

J. Granada, P. Buszman, J. Drzewiecki, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A patient with angina at night: core curriculum chapters 3 (non-invasive imaging) and 9 (chronic ischaemic heart disease)

F. Eberli, A. Wieczorek, A. Kastrati, 2012 .

Evaluation of safety and efficacy of NexGen – an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real life patient population – the Polish NexGen Registry

P. Buszman, P. Gąsior, W. Wojakowski, 2016, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

VALUE OF THE SYNTAX SCORE (SX) FOR RISK ASSESSMENT IN THE “ALL-COMERS” POPULATION OF THE RANDOMIZED MULTICENTER LEADERS TRIAL.

F. Eberli, P. Serruys, J. Wykrzykowska, 2010 .

Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.

A. Zurakowski, P. Buszman, K. Milewski, 2007, Kardiologia polska.

Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.

J. Granada, A. Zurakowski, P. Buszman, 2018, JACC. Cardiovascular interventions.

[Programmed electrical stimulation of the heart in relation to left ventricular contractility in ischemic heart disease].

A. Dąbrowski, Z. Gąsior, P. Buszman, 1990, Kardiologia polska.

Coronary artery stenosis in patients with valvular heart disease.

P. Buszman, W. Pluta, A. Lekston, 1989, Cor et vasa.

Long‐term results of cephalad arteries percutanoeus transluminal angioplasty with stent implantation (The CAPTAS registry)

P. Buszman, M. Radvany, Marcin Dębiński, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of air pollution on hospital patients admitted with ST- and non-ST-segment elevation myocardial infarction in heavily polluted cities within the European Union.

P. Buszman, M. Cisowski, K. Milewski, 2013, Cardiology journal.

Impact of air pollution on hospital patients admitted with STand non-ST-segment elevation myocardial infarction in heavily polluted cities within the European Union

Patrycja, P. Buszman, M. Cisowski, 2022 .

Prevalence, characteristics and prognostic implications of type 2 diabetes in patients with myocardial infarction: PL-ACS Registry annual report 2018.

M. Lelonek, T. Zdrojewski, P. Buszman, 2020, Kardiologia polska.

Assessment of quality of care of patients with ST-segment elevation myocardial infarction

A. Budaj, D. Dudek, T. Zdrojewski, 2019, European heart journal. Acute cardiovascular care.

TCT-44 LEADERS: 5-Year Follow-Up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Biodegradable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer- Final report of the LEADERS study

F. Eberli, P. Serruys, S. Windecker, 2012 .

Long-term results of cephalad arteries percutanoeus transluminal angioplasty with stent implantation (The CAPTAS registry).

P. Buszman, M. Radvany, Marcin Dębiński, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term results of cephalad arteries percutanoeus transluminal angioplasty with stent implantation (The CAPTAS registry).

P. Buszman, M. Radvany, Marcin Dębiński, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design of RESTORE, a randomized clinical trial

R. Piotrowicz, A. Małecki, P. Buszman, 2019, Cardiology journal.

Comparison of long-term outcomes after directional versus rotational atherectomy in peripheral artery disease

P. Buszman, W. Wojakowski, K. Milewski, 2020, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Long-term bio-functional performance of a novel, self-positioning balloon expandable transcatheter biological aortic valve system in the ovine aortic banding model.

P. Buszman, A. Bochenek, M. Sobota, 2023, Cardiology journal.

Local paclitaxel delivery as a treatment of persistent, recurrent in-stent restenosis -- safety assessment.

M. Tendera, A. Zurakowski, P. Buszman, 2006, Kardiologia polska.

Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).

M. Tendera, P. Buszman, A. Ochała, 2013, Minerva cardioangiologica.

Comparison of stenting and surgical revascularization strategy in non-ST elevation acute coronary syndromes and complex coronary artery disease (from the Milestone Registry).

M. Zembala, P. Buszman, A. Bochenek, 2014, The American journal of cardiology.

Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model.

J. Granada, P. Buszman, J. Prats, 2012, Thrombosis research.

Long-term outcomes of the Coordinated Care Program in Patients after Myocardial Infarction (KOS-MI).

A. Zurakowski, P. Jankowski, P. Buszman, 2023, Kardiologia polska.

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Long-Term Outcomes After Percutaneous Lower Extremity Arterial Interventions With Atherectomy vs. Balloon Angioplasty　- Propensity Score-Matched Registry.

P. Buszman, W. Wojakowski, K. Milewski, 2017, Circulation journal : official journal of the Japanese Circulation Society.

Safety and feasibility of same‐day early discharge after endovascular revascularization of lower extremities in elderly. SENIOR‐ER registry

A. Zurakowski, P. Buszman, K. Milewski, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

S. Pocock, P. Serruys, G. Stone, 2016, The New England journal of medicine.

Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.

Seung‐Jung Park, R. Mehran, M. Valgimigli, 2016, JACC. Cardiovascular interventions.

Causes of hospitalization and prognosis in patients with cardiovascular diseases. Secular trends in the years 2006-2014 according to the SILesian CARDiovascular (SILCARD) database.

M. Zembala, M. Tendera, P. Buszman, 2016, Polskie Archiwum Medycyny Wewnetrznej.

P. Serruys, R. D. de Winter, A. Zurakowski, 2017, The Lancet.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, M. Joner, 2010 .

Hemostatic disorders in patients with infective endocarditis undergoing urgent surgical valve replacement - Rethinking current beliefs.

P. Buszman, K. Milewski, P. Buszman, 2023, International journal of cardiology.

A case of multiple giant right coronary artery aneurysms.

P. Buszman, M. Sosnowski, Ewa Peszek-Przybyła, 2011, Cardiology journal.

Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry.

O. Alfieri, I. Palacios, P. Serruys, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent

M. Morice, W. Wijns, P. Buszman, 2013, JACC. Cardiovascular interventions.

feasibility and safety study: The ACTION trial Actinomycin-eluting stent for coronary revascularization: A randomized

P. Serruys, A. Schömig, A. Zeiher, 2011 .

PERIPHERAL VASCULAR DISEASE Original Studies Long-term Results of Plaque Excision Combined with Aggressive Pharmacotherapy in High-Risk Patients with Advanced Peripheral Artery Disease (SAVE A LEG Registry)

P. Buszman, M. Radvany, P. Buszman, 2013 .

Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry).

M. Tendera, P. Buszman, A. Bochenek, 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Dose-dependent vascular response following delivery of sirolimus via fast releasing, biodegradable polymer stent matrix: an experimental study in the porcine coronary model of restenosis

P. Buszman, K. Milewski, P. Buszman, 2015 .